| scholarly article | Q13442814 |
| P50 | author | Casey M Wright | Q58452379 |
| P2093 | author name string | Kwun M Fong | |
| Michael R Green | |||
| Ling Lin | |||
| Arvindhan Nagarajan | |||
| Narendra Wajapeyee | |||
| Romi Gupta | |||
| Lihua J Zhu | |||
| Lynn Chamberlain | |||
| Magnolia L Pak | |||
| P2860 | cites work | Ponatinib (AP24534), a multitargeted pan-FGFR inhibitor with activity in multiple FGFR-amplified or mutated cancer models | Q39413387 |
| Genome-wide DNA methylation profiling using Infinium® assay | Q39793806 | ||
| An elaborate pathway required for Ras-mediated epigenetic silencing | Q40062561 | ||
| The insulin-like growth factor type 1 and insulin-like growth factor type 2/mannose-6-phosphate receptors independently regulate ERK1/2 activity in HEK293 cells. | Q40109540 | ||
| Genetic and epigenetic regulation of the human prostacyclin synthase promoter in lung cancer cell lines | Q40156311 | ||
| Individual overexpression of five subunits of human translation initiation factor eIF3 promotes malignant transformation of immortal fibroblast cells | Q40196128 | ||
| Immortalization and transformation of primary human airway epithelial cells by gene transfer. | Q40722115 | ||
| Stimulation of human extravillous trophoblast migration by IGF-II is mediated by IGF type 2 receptor involving inhibitory G protein(s) and phosphorylation of MAPK. | Q40786394 | ||
| Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene | Q42806006 | ||
| erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells | Q42807469 | ||
| Transformation of NIH 3T3 cells by microinjection of Ha-ras p21 protein | Q42818191 | ||
| Ligand-independent activation of tyrosine kinase in fibroblast growth factor receptor 1 by fusion with beta-galactosidase | Q42826751 | ||
| Regulation of EP receptors in non-small cell lung cancer by epigenetic modifications. | Q43264261 | ||
| Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer | Q81795190 | ||
| Cellular signaling by fibroblast growth factor receptors | Q24301087 | ||
| Identification and characterization of three members of the human SR family of pre-mRNA splicing factors | Q24309346 | ||
| COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer | Q24608391 | ||
| Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks | Q24633890 | ||
| Misregulation of pre-mRNA alternative splicing in cancer | Q27007114 | ||
| Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer. | Q27851615 | ||
| Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer | Q27851654 | ||
| Gene Expression Omnibus: NCBI gene expression and hybridization array data repository | Q27860523 | ||
| 90-kDa ribosomal S6 kinase is a direct target for the nuclear fibroblast growth factor receptor 1 (FGFR1): role in FGFR1 signaling | Q28259259 | ||
| Toll-like receptors are key participants in innate immune responses | Q28260225 | ||
| Comprehensive genomic characterization of squamous cell lung cancers | Q28274701 | ||
| Second-generation shRNA libraries covering the mouse and human genomes | Q28275183 | ||
| Molecular cloning and characterization of a protein tyrosine phosphatase enriched in testis, a putative murine homologue of human PTPMEG | Q28591701 | ||
| Proteomic characterization of novel alternative splice variant proteins in human epidermal growth factor receptor 2/neu-induced breast cancers | Q30388028 | ||
| The interactive online SKY/M-FISH & CGH database and the Entrez cancer chromosomes search database: linkage of chromosomal aberrations with the genome sequence | Q34016358 | ||
| Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer. | Q34206495 | ||
| A mutator phenotype in cancer. | Q34222899 | ||
| GAPex-5 mediates ubiquitination, trafficking, and degradation of epidermal growth factor receptor | Q34633785 | ||
| Epigenetic gene silencing in cancer: the DNA hypermethylome | Q34646556 | ||
| Molecular concepts analysis links tumors, pathways, mechanisms, and drugs | Q35812701 | ||
| Alterations of pre-mRNA splicing in cancer. | Q36008085 | ||
| Induction of transformation and DNA synthesis after microinjection of raf proteins | Q36717338 | ||
| Semaphorins in lung cancer | Q36780590 | ||
| Cancer genome sequencing: a review | Q37379481 | ||
| Rapid creation and quantitative monitoring of high coverage shRNA libraries | Q37440284 | ||
| Loss-of-function genetic screens as a tool to improve the diagnosis and treatment of cancer | Q37600610 | ||
| Role of class 3 semaphorins and their receptors in tumor growth and angiogenesis | Q37627002 | ||
| Biology and significance of signalling pathways activated by IGF-II. | Q37963987 | ||
| Targeting LKB1 signaling in cancer. | Q38071485 | ||
| Fibroblast growth factor receptor inhibitors as a cancer treatment: from a biologic rationale to medical perspectives | Q38082503 | ||
| FGFR genetic alterations predict for sensitivity to NVP-BGJ398, a selective pan-FGFR inhibitor. | Q39273183 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 1168-1181 | |
| P577 | publication date | 2014-07-11 | |
| P1433 | published in | Cancer Discovery | Q15724440 |
| P1476 | title | A large-scale RNAi-based mouse tumorigenesis screen identifies new lung cancer tumor suppressors that repress FGFR signaling | |
| P478 | volume | 4 |
| Q37701569 | Combination treatment of prostate cancer with FGF receptor and AKT kinase inhibitors |
| Q38717741 | Identification of proteasomal catalytic subunit PSMA6 as a therapeutic target for lung cancer. |
| Q88938127 | In vivo RNAi screening identifies Pafah1b3 as a target for combination therapy with TKIs in BCR-ABL1+ BCP-ALL |
| Q90561856 | Loss of thymidine kinase 1 inhibits lung cancer growth and metastatic attributes by reducing GDF15 expression |
| Q94545721 | Phenotypic screening using large-scale genomic libraries to identify drug targets for the treatment of cancer |
| Q47917013 | RACK1 forms a complex with FGFR1 and PKM2, and stimulates the growth and migration of squamous lung cancer cells |
| Q33902592 | Serine hydroxymethyl transferase 1 stimulates pro-oncogenic cytokine expression through sialic acid to promote ovarian cancer tumor growth and progression |
| Q55443707 | [Progress on the Study of Targeting FGFR in Squamous Non-small Cell Lung Cancer]. |
Search more.